Lactose intolerance in irritable bowel syndrome patients with diarrhoea: The roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 3, 2014, Pages 302-311

  Yang, J ^a,b   Fox, M ^c,d   Cong, Y ^a   Chu, H ^a   Zheng, X ^a   Long, Y ^a   Fried, M ^c,e   Dai, N ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL DISEASE; ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; ASCENDING COLON; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYDROGEN BREATH TEST; HYPERSENSITIVITY; ILEUM; INTESTINE BIOPSY; IRRITABLE COLON; LACTOSE HYDROGEN BREATH TEST; LACTOSE INTOLERANCE; LIFE EVENT; LIFE STRESS; MAJOR CLINICAL STUDY; MALE; MAST CELL; MEASUREMENT; MUCOSAL IMMUNITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECTAL SENSITIVITY; SIGMOID; VISCERAL HYPERSENSITIVITY;

ADULT; ANIMALS; ANXIETY; BREATH TESTS; CASE-CONTROL STUDIES; DIARRHEA; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; IRRITABLE BOWEL SYNDROME; LACTOSE; LACTOSE INTOLERANCE; LACTOSE TOLERANCE TEST; MALABSORPTION SYNDROMES; MALE; MAST CELLS; MIDDLE AGED; PREVALENCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84891847336     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12582     Document Type: Article

References (31)

1. Lomer MC, Parkes GC, Sanderson JD,. Review article: lactose intolerance in clinical practice-myths and realities. Aliment Pharmacol Ther 2008; 27: 93-103.
2. Suchy FJ, Brannon PM, Carpenter TO, et al,. National Institutes of Health Consensus Development Conference: lactose intolerance and health. Ann Intern Med 2010; 152: 792-6.
3. Misselwitz B, Pohl D, Frühauf H, Fried M, Vavricka SR, Fox M,. Lactose malabsorption and intolerance:pathogensis, diagnosis and treatment. United Eur Gastroenterol J 2013; 1: 151-9.
4. Shepherd SJ, Parker FC, Muir JG, Gibson PR,. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008; 6: 765-71.
5. Monsbakken KW, Vandvik PO, Farup PG,. Perceived food intolerance in subjects with irritable bowel syndrome- etiology, prevalence and consequences. Eur J Clin Nutr 2006; 60: 667-72.
6. Le NB, Posserud I, Bohn L, et al,. A combined nutrient and lactulose challenge test allows symptom-based clustering of patients with irritable bowel syndrome. Am J Gastroenterol 2013; 108: 786-95.
7. Di Stefano M, Miceli E, Mazzocchi S, Tana P, Moroni F, Corazza GR,. Visceral hypersensitivity and intolerance symptoms in lactose malabsorption. Neurogastroenterol Motil 2007; 19: 887-95.
8. Simren M, Abrahamsson H, Bjornsson ES,. Lipid-induced colonic hypersensitivity in the irritable bowel syndrome: the role of bowel habit, sex, and psychologic factors. Clin Gastroenterol Hepatol 2007; 5: 201-8.
9. Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW,. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol 2008; 23: 1689-94.
10. Chadwick VS, Chen W, Shu D, et al,. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002; 122: 1778-83.
11. de Medeiros MT, Carvalho AF, de Oliveira Lima JW, Dos SAA, de Oliveira RB, Nobre ESMA,. Impact of depressive symptoms on visceral sensitivity among patients with different subtypes of irritable bowel syndrome. J Nerv Ment Dis 2008; 196: 711-4.
12. Foley S, Garsed K, Singh G, et al,. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterology 2011; 140: 1434-43, e1.
13. Barbara G, Wang B, Stanghellini V, et al,. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007; 132: 26-37.
14. Buhner S, Li Q, Vignali S, et al,. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 2009; 137: 1425-34.
15. Gwee KA, Graham JC, McKendrick MW, et al,. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996; 347: 150-3.
16. Yang J, Deng Y, Chu H, et al,. Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013; 11: 262-8, e1.
17. Zhu Y, Zheng X, Cong Y, et al,. Bloating and distention in irritable bowel syndrome: the role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency. Am J Gastroenterol 2013; 108: 1516-25.
18. Sauter M, Heinrich H, Fox M, et al,. Towards more accurate measurements of anorectal motor and sensory function in routine clinical practice: validation of high resolution anorectal manometry and rapid barostat bag measurements of rectal function. Neurogastroenterol Motil 2013; in press.
19. O'Sullivan M, Clayton N, Breslin NP, et al,. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000; 12: 449-57.
20. Park JH, Rhee PL, Kim HS, et al,. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. J Gastroenterol Hepatol 2006; 21: 71-8.
21. Cremon C, Gargano L, Morselli-Labate AM, et al,. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 2009; 104: 392-400.
22. Barrett JS, Irving PM, Shepherd SJ, Muir JG, Gibson PR,. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther 2009; 30: 165-74.
23. Tomba C, Baldassarri A, Coletta M, Cesana BM, Basilisco G,. Is the subjective perception of lactose intolerance influenced by the psychological profile. Aliment Pharmacol Ther 2012; 36: 660-9.
24. Barreau F, Salvador-Cartier C, Houdeau E, Bueno L, Fioramonti J,. Long-term alterations of colonic nerve-mast cell interactions induced by neonatal maternal deprivation in rats. Gut 2008; 57: 582-90.
25. Siddiqui AA, Miner PB Jr,. The role of mast cells in common gastrointestinal diseases. Curr Allergy Asthma Rep 2004; 4: 47-54.
26. Lunardi C, Bambara LM, Biasi D, et al,. Double-blind cross-over trial of oral sodium cromoglycate in patients with irritable bowel syndrome due to food intolerance. Clin Exp Allergy 1991; 21: 569-72.
27. Klooker TK, Braak B, Koopman KE, et al,. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 2010; 59: 1213-21.
28. Di Stefano M, Miceli E, Missanelli A, Mazzocchi S, Tana P, Corazza GR,. Role of colonic fermentation in the perception of colonic distention in irritable bowel syndrome and functional bloating. Clin Gastroenterol Hepatol 2006; 4: 1242-7.
29. Farup PG, Monsbakken KW, Vandvik PO,. Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case-control study. Scand J Gastroenterol 2004; 39: 645-9.
30. Konturek PC, Brzozowski T, Konturek SJ,. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol 2011; 62: 591-9.
31. Vicario M, Guilarte M, Alonso C, et al,. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress. Brain Behav Immun 2010; 24: 1166-75.